- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Aromatase Inhibitors
Total 63848 results
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
PfizerCompleted
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterActive, not recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
University of MichiganRecruitingArthralgia | Aging | Breast Neoplasm FemaleUnited States
-
King Faisal Specialist Hospital & Research CenterUnknownAdvanced Breast CancerSaudi Arabia
-
University of Wisconsin, MadisonCompletedBreast Cancer | Osteoporosis | Osteopenia | Fracture
-
UNICANCERAgendiaRecruiting
-
Nemours Children's ClinicNovartis; Pfizer; AstraZeneca; Genentech, Inc.; Thrasher Research FundCompletedIdiopathic Short StatureUnited States, Chile
-
MedImmune LLCCompletedHormone-sensitive, HER-2 Negative Metastatic Breast CancerSpain, United States, Belgium, France, United Kingdom, Canada, Israel, Germany, Hungary, Poland, Bahamas
-
American University of Beirut Medical CenterWithdrawnSymptomatic or Large Uterine FibroidsLebanon
-
Mridula George, MDRecruiting
-
Eli Lilly and CompanyWithdrawnMetastatic Breast CancerUnited States, Taiwan, Italy, Austria, Germany, Puerto Rico, Belgium, Argentina, Brazil
-
Sven O. SkoubyRigshospitalet, Denmark; Region Capital Denmark; Copenhagen University Hospital...Completed
-
Sven O. SkoubyZealand University Hospital; Rigshospitalet, Denmark; Hvidovre University Hospital and other collaboratorsCompleted
-
Centro Hospitalar Lisboa OcidentalUnknownBreast Cancer Female | Hormone Dependent NeoplasmsPortugal
-
Syndax PharmaceuticalsCompleted
-
Ain Shams UniversityUnknown
-
PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Hormone Receptor Positive TumorSweden
-
Dana-Farber Cancer InstituteEli Lilly and CompanyWithdrawnBreast Cancer
-
Korea University Anam HospitalKorea UniversityUnknownBreast Neoplasms | Arthritis | Arthralgia | Genetic PolymorphismKorea, Republic of
-
Marina N SharifiNovartis; University of Wisconsin, MadisonRecruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | PIK3CA Mutant Metastatic Breast CancerUnited States
-
Nicholas MacklonGedeon Richter Ltd.; IgenomixCompleted
-
Alison StopeckEli Lilly and Company; AstraZenecaWithdrawnLocally Advanced Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleUnited States
-
Novartis PharmaceuticalsGlaxoSmithKlineCompletedNeoplasms, BreastBelgium, United Kingdom, Croatia, Hungary, Argentina, Australia, Germany, Israel, Japan, Poland, Russian Federation, Spain, France, Korea, Republic of, Hong Kong, United States, Brazil, Bulgaria, China, India, Ireland, Italy, Philip... and more
-
Eli Lilly and CompanyCompletedBreast Neoplasms | Neoplasm MetastasisIndia
-
Mỹ Đức HospitalCompletedPoor Ovarian ResponseVietnam
-
Prof. Wolfgang JanniEli Lilly and CompanyRecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast CancerGermany, Switzerland
-
NHS TaysideCompleted
-
Xichun HuCompletedMetastatic Breast CancerChina
-
Second Affiliated Hospital, School of Medicine,...GeneCast Biotechnology Co., Ltd.RecruitingLuminal B/HER2-negative Breast CancerChina
-
NRG OncologyNational Cancer Institute (NCI)Recruiting
-
Monica MitaCedars-Sinai Medical CenterTerminated
-
PfizerCompleted
-
Consorzio OncotechUnknown
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
International Cancer Research Group, United Arab...King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut... and other collaboratorsRecruitingHormonal Receptors Positive, HER2 Negative, Advanced Breast CancerAlgeria, Jordan, Saudi Arabia
-
British Columbia Cancer AgencyJanssen Research & Development, LLCWithdrawnPost-menopausal ER+ Stage I-IIIA Primary Operable Breast CancerCanada
-
Nik HazlinaCompletedPolycystic Ovarian Syndrome
-
Rigshospitalet, DenmarkCompleted
-
Tvardi Therapeutics, IncorporatedActive, not recruiting
-
PfizerCompletedBreast NeoplasmsQatar, United Arab Emirates, Saudi Arabia
-
Dharmais National Cancer Center HospitalCompleted
-
Tianjin Medical UniversityUnknown
-
Minia UniversityCompletedInfertility Indicated for ICSIEgypt
-
Eli Lilly and CompanyActive, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Endometrial CancerUnited States, Spain, France, Belgium, Taiwan, Australia, Korea, Republic of, Japan
-
PfizerActive, not recruiting